🇺🇸 Ticagrelor 90mg in United States

39 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Dyspnoea — 13 reports (33.33%)
  2. Respiratory Depression — 5 reports (12.82%)
  3. Wheezing — 4 reports (10.26%)
  4. Cough — 3 reports (7.69%)
  5. Haemoglobin Decreased — 3 reports (7.69%)
  6. Heart Rate Irregular — 3 reports (7.69%)
  7. Anaemia — 2 reports (5.13%)
  8. Asthenia — 2 reports (5.13%)
  9. Atrioventricular Block Second Degree — 2 reports (5.13%)
  10. Blood Creatinine Increased — 2 reports (5.13%)

Source database →

Ticagrelor 90mg in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Ticagrelor 90mg approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Ticagrelor 90mg in United States?

University of Arkansas is the originator. The local marketing authorisation holder may differ — check the official source linked above.